{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:27:12Z","timestamp":1743740832736,"version":"3.40.3"},"reference-count":58,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aktuelle Urol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\n    Geschlechtsunterschiede in der Medizin spielen mittlerweile eine nicht mehr wegzudenkende Rolle, sowohl in Diagnostik als auch Therapie. Risikofaktoren und Mortalit\u00e4t variieren je nach Geschlecht, Krankheiten \u00e4u\u00dfern sich unterschiedlich. In der Diagnostik m\u00fcssen je nach Geschlecht unterschiedliche Aspekte in Betracht gezogen werden. Bei Blasenkarzinomen zum Beispiel kommt es bei Frauen h\u00e4ufig zu Verz\u00f6gerungen bei der Diagnose, weil H\u00e4maturie oft benignen Erkrankungen wie Harnwegsinfekten zugeschrieben wird.    \n    Bei Therapieentscheidungen sollte das Geschlecht ebenso eine Rolle spielen. Um ein Beispiel zu nennen, haben Immuncheckpoint-Inhibitoren bei Nierenzellkarzinomen bei M\u00e4nnern ein besseres Ansprechen als bei Frauen. Auch die Outcomes nach onkologischer Therapie bei urologischen Tumoren variieren nach Geschlecht.\n    <\/jats:p>","DOI":"10.1055\/a-2552-1170","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T23:21:15Z","timestamp":1743722475000},"page":"158-163","source":"Crossref","is-referenced-by-count":0,"title":["Geschlechtsspezifische Unterschiede urologischer Tumore"],"prefix":"10.1055","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4858-5759","authenticated-orcid":false,"given":"Julia","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Resch","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"M Burger","year":"2013","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907975","article-title":"A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery","volume":"12","author":"M Pallauf","year":"2022","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"A Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000368418","article-title":"Sex Differences of \u2265 pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients","volume":"94","author":"T Waldhoer","year":"2015","journal-title":"Urol Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends","volume":"71","author":"S Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clgc.2019.10.020","article-title":"Sex Differences in Urothelial Bladder Cancer Survival","volume":"18","author":"C Radkiewicz","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"LA Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cncr.23986","article-title":"Sex and racial differences in bladder cancer presentation and mortality in the US","volume":"115","author":"E Scosyrev","year":"2009","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-011-0709-9","article-title":"Impact of gender on bladder cancer incidence, staging, and prognosis","volume":"29","author":"H Fajkovic","year":"2011","journal-title":"World J Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2013.11.040","article-title":"Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients","volume":"66","author":"LA Kluth","year":"2014","journal-title":"Eur Urol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrurol.2015.257","article-title":"Gender differences in incidence and outcomes of urothelial and kidney cancer","volume":"12","author":"I Lucca","year":"2015","journal-title":"Nat Rev Urol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2024.102723","article-title":"Sex differences in muscle-invasive bladder cancers: a study of a French regional population","volume":"35","author":"C Poli","year":"2024","journal-title":"Fr J Urol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"J Palou","year":"2012","journal-title":"Eur Urol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"J Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/s0090-4295(99)00481-1","article-title":"Gender differences in stage distribution of bladder cancer","volume":"55","author":"NA Mungan","year":"2000","journal-title":"Urology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"ND Freedman","year":"2011","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2796.2002.01022.x","article-title":"Tobacco use and cancer causation: association by tumour type","volume":"252","author":"H Kuper","year":"2002","journal-title":"J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.toxlet.2009.12.018","article-title":"Environmental factors and genetic susceptibility promote urinary bladder cancer","volume":"193","author":"D Volanis","year":"2010","journal-title":"Toxicol Lett"},{"key":"ref24","first-page":"1","article-title":"Surveillance for cancers associated with tobacco use--United States 1999\u20132004","volume":"57","author":"SL Stewart","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.juro.2008.03.045","article-title":"The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation","volume":"180","author":"SA Strope","year":"2008","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"17420","DOI":"10.18632\/oncotarget.24724","article-title":"Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years","volume":"9","author":"L Jacob","year":"2018","journal-title":"Oncotarget"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174746","article-title":"Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies","volume":"12","author":"H Ide","year":"2017","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes","volume":"69","author":"J Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00345-022-04116-x","article-title":"Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis","volume":"41","author":"K Mori","year":"2023","journal-title":"World J Urol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients","volume":"33","author":"W Martin-Doyle","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.euf.2017.08.007","article-title":"Gender-specific Differences in Recurrence of Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","volume":"4","author":"A Uhlig","year":"2018","journal-title":"Eur Urol Focus"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00345-012-0996-9","article-title":"Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder","volume":"31","author":"LA Kluth","year":"2013","journal-title":"World J Urol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1007\/s00345-021-03653-1","article-title":"Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Gu\u00e9rin immunotherapy for T1G3\/HG bladder cancer","volume":"39","author":"D D'Andrea","year":"2021","journal-title":"World J Urol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"27325","DOI":"10.18632\/oncotarget.8756","article-title":"Targeting estrogen\/estrogen receptor alpha enhances Bacillus Calmette-Gu\u00e9rin efficacy in bladder cancer","volume":"7","author":"Z Shang","year":"2016","journal-title":"Oncotarget"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00345-011-0773-1","article-title":"Gender-dependent cancer-specific survival following radical cystectomy","volume":"30","author":"M May","year":"2012","journal-title":"World J Urol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.urology.2013.10.060","article-title":"Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis","volume":"83","author":"JC Messer","year":"2014","journal-title":"Urology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1097\/01.ju.0000093721.23249.c3","article-title":"Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors","volume":"170","author":"AL Zietman","year":"2003","journal-title":"J Urol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1016\/j.clon.2023.02.005","article-title":"Differences in Quality of Life and Toxicity for Male and Female Patients following Chemo(radiotherapy) for Bladder Cancer","volume":"35","author":"L Philipps","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","volume":"71","author":"JA Witjes","year":"2017","journal-title":"Eur Urol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.eururo.2014.09.007","article-title":"Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"67","author":"H Zargar","year":"2015","journal-title":"Eur Urol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.30029","article-title":"Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer","volume":"122","author":"TL Rose","year":"2016","journal-title":"Cancer"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/01.ju.0000091620.86778.2e","article-title":"Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program","volume":"170","author":"BR Konety","year":"2003","journal-title":"J Urol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.euf.2019.06.001","article-title":"Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy","volume":"7","author":"MJ Krimphove","year":"2021","journal-title":"Eur Urol Focus"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.juro.2017.11.150","article-title":"Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"200","author":"A Uhlig","year":"2018","journal-title":"J Urol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"639.e1","DOI":"10.1016\/j.urolonc.2020.01.010","article-title":"Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer","volume":"38","author":"D D'Andrea","year":"2020","journal-title":"Urol Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.euo.2024.03.014","article-title":"Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis","volume":"7","author":"C Cerrato","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00345-023-04412-0","article-title":"Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis","volume":"41","author":"T Yanagisawa","year":"2023","journal-title":"World J Urol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/BLC-170162","article-title":"Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer","volume":"4","author":"NJ Farber","year":"2018","journal-title":"Bladder Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.21037\/tau-22-463","article-title":"Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review","volume":"11","author":"M von Deimling","year":"2022","journal-title":"Transl Androl Urol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-018-6381-1","article-title":"Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014","volume":"25","author":"C Groeben","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.urology.2005.10.015","article-title":"Neurovascular preservation in orthotopic cystectomy: impact on female sexual function","volume":"67","author":"A Bhatt","year":"2006","journal-title":"Urology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.urology.2003.12.034","article-title":"Female sexual dysfunction after radical cystectomy: a new outcome measure","volume":"63","author":"CD Zippe","year":"2004","journal-title":"Urology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.juro.2012.03.004","article-title":"Voiding function in women with orthotopic neobladder urinary diversion","volume":"188","author":"CB Anderson","year":"2012","journal-title":"J Urol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.juro.2011.05.069","article-title":"Urinary retention after orthotopic neobladder substitution in females","volume":"186","author":"DS Finley","year":"2011","journal-title":"J Urol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.juro.2016.11.094","article-title":"A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States","volume":"197","author":"N Singla","year":"2017","journal-title":"J Urol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/JU.0000000000000788","article-title":"Differential Effect of Sex on Outcomes after Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis","volume":"204","author":"K Mori","year":"2020","journal-title":"J Urol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MOU.0000000000000893","article-title":"Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Part 1","volume":"31","author":"K Zimmermann","year":"2021","journal-title":"Curr Opin Urol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.eururo.2021.01.032","article-title":"Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes","volume":"79","author":"JWF Catto","year":"2021","journal-title":"Eur Urol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41585-022-00693-z","article-title":"Health-related quality of life after curative treatment for muscle-invasive bladder cancer","volume":"20","author":"E Grobet-Jeandin","year":"2023","journal-title":"Nat Rev Urol"}],"container-title":["Aktuelle Urologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2552-1170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T23:24:07Z","timestamp":1743722647000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2552-1170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":58,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2552-1170","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0001-7868","1438-8820"],"issn-type":[{"value":"0001-7868","type":"print"},{"value":"1438-8820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}